Every material Form 8-K abrdn Healthcare Investors filed with the SEC in 2012, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
The Board of Trustees authorized a renewal of the fund's share repurchase program, which allows open-market purchases of up to 12% of outstanding common shares for one year starting July 11, 2012. The board says the program aims to raise net asset value per share and narrow the gap between the share price and net asset value.
Renewed program allows open-market purchases of up to 12% of outstanding common shares
Current program runs through July 10, 2012; renewal covers the one-year period beginning July 11, 2012
Amount and timing of repurchases are at the discretion of investment adviser Hambrecht & Quist Capital Management LLC
Filing states there is no assurance of purchases at any specific discount level, amount or date
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every abrdn Healthcare Investors filing is on SEC EDGAR ↗. 8-K briefs of other companies →